Document is current
Any future updates will be listed below
-
Authors
Groen, J. A.
Zweije, R.
Sijbrands, J.
Scutigliani, E. M.
van Laarhoven, H. W. M.
Bijlsma, M. F.
Crezee, J.
Kok, H. P.
-
Funding
Funding for this research was provided by:
KWF Kankerbestrijding (2020-1 2985, 2020-1 2985)
- License Information
-
More Information
Article History
Received: 6 June 2025
Accepted: 23 September 2025
First Online: 29 October 2025
Declarations
:
: J. Crezee and H.P. Kok have a research collaboration with Med-Logix srl. Med-Logix had no role in the study design, analyses, or interpretation of data, in the writing of the article, or in the decision to publish the results. M.F. Bijlsma has received research funding from Celgene, Frame Therapeutics, and Lead Pharma, and has acted as a consultant to Servier, Olympus and Wholomics. Other authors have no competing interest.
